Mahendra Tri Arif Sampurna, - and Kian Djien Liem, - and Danny Chandra Pratama, - and Novita Oktaviana, - and Achmad Januar Er Putra, - and Rahmi Zakiyah, - and Visuddho, - and Risa Etika, - and Kartika Dharma Handayani, - and Martono Tri Utomo, - and Dina Angelica, - and Wurry Ayuningtyas, - and Toto Wisnu Hendrarto, - and Rinawati Rohsiswatmo, - and Setya Wandita, - and Risma Karina Kaban, - and Jordy Maulana Ahmad, - (2022) A review of existing neonatal hyperbilirubinemia guidelines in Indonesia. F1000Research, 11 (1534). pp. 1-14. ISSN 2046-1402

	Text (Artikel) Artikel 1.pdf Download (897kB)
	Text (Karil) FORM KARIL 1.pdf Download (139kB)
	Text (Similarity) Similarity 1.pdf Download (3MB)

Abstract

Background: Neonatal hyperbilirubinemia is one of the most common conditions for neonate inpatients. Indonesia faces a major challenge in which different guidelines regarding the management of this condition were present. This study aimed to compare the existing guidelines regarding prevention, diagnosis, treatment and monitoring in order to create the best recommendation for a new hyperbilirubinemia guideline in Indonesia. Methods: Through an earlier survey regarding adherence to the neonatal hyperbilirubinemia guideline, we identified that three main guidelines are being used in Indonesia. These were developed by the Indonesian Pediatric Society (IPS), the Ministry of Health (MoH), and World Health Organization (WHO). In this study, we compared factors such as prevention, monitoring, methods for identifying, risk factors in the development of neonatal jaundice, risk factors that increase brain damage, and intervention treatment threshold in the existing guidelines to determine the best recommendations for a new guideline. Results: The MoH and WHO guidelines allow screening and treatment of hyperbilirubinemia based on visual examination (VE) only. Compared with the MoH and WHO guidelines, risk assessment is comprehensively discussed in the IPS guideline. The MoH guideline recommends further examination of an icteric baby to ensure that the mother has enough milk without measuring the bilirubin level. The MoH guideline recommends referring the baby when it looks yellow on the soles and palms. The WHO and IPS guidelines recommend combining VE with an objective measurement of transcutaneous or serum bilirubin. The threshold to begin phototherapy in the WHO guideline is lower than the IPS guideline while the exchange transfusion threshold in both guidelines are comparably equal. Conclusions: The MoH guideline is outdated. MoH and IPS guidelines are causing differences in approaches to the management hyperbilirubinemia. A new, uniform guideline is required.

Item Type:	Article
Uncontrolled Keywords:	icterus, neonates, recommendations, LMIC
Subjects:	R Medicine > R Medicine (General) R Medicine > RJ Pediatrics
Divisions:	01. Fakultas Kedokteran > Ilmu Kesehatan Anak (Sub Spesialis)
Creators:	Creators NIM Mahendra Tri Arif Sampurna, - NIDN0025018302 Kian Djien Liem, - UNSPECIFIED Danny Chandra Pratama, - UNSPECIFIED Novita Oktaviana, - UNSPECIFIED Achmad Januar Er Putra, - UNSPECIFIED Rahmi Zakiyah, - UNSPECIFIED Visuddho, - UNSPECIFIED Risa Etika, - NIDN8817800016 Kartika Dharma Handayani, - UNSPECIFIED Martono Tri Utomo, - NIDN0026017304 Dina Angelica, - UNSPECIFIED Wurry Ayuningtyas, - UNSPECIFIED Toto Wisnu Hendrarto, - UNSPECIFIED Rinawati Rohsiswatmo, - UNSPECIFIED Setya Wandita, - UNSPECIFIED Risma Karina Kaban, - UNSPECIFIED Jordy Maulana Ahmad, - UNSPECIFIED
Depositing User:	arys fk
Date Deposited:	06 Jun 2023 05:13
Last Modified:	06 Jun 2023 05:13
URI:	http://repository.unair.ac.id/id/eprint/126978
Sosial Share:

Actions (login required)

View Item